{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:32:29Z","timestamp":1788312749008,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jcin.2018.08.034","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T16:45:14Z","timestamp":1543855514000},"page":"2357-2364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon"],"prefix":"10.1016","volume":"11","author":[{"given":"Marianne","family":"Brodmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk-Roelfs","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Granada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Jaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2018.08.034_bib1","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2018.08.034_bib2","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2018.08.034_bib3","unstructured":"Dake M. The Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal artery disease: 5-year results. Presented at: VIVA 2014; Las Vegas, Nevada."},{"key":"10.1016\/j.jcin.2018.08.034_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2011.09.036","article-title":"Classification and clinical impact of restenosis after femoropopliteal stenting","volume":"59","author":"Tosaka","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2018.08.034_bib5","doi-asserted-by":"crossref","first-page":"e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2018.08.034_bib6","unstructured":"Laurich C. Oral presentation. Presented at: SVS; June 18, 2015; Chicago, Illinois."},{"key":"10.1016\/j.jcin.2018.08.034_bib7","first-page":"278","article-title":"Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study","volume":"86","author":"Schroeder","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2018.08.034_bib8","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","volume":"135","author":"Schroeder","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2018.08.034_bib9","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2018.08.034_bib10","doi-asserted-by":"crossref","first-page":"e000117","DOI":"10.1136\/openhrt-2014-000117","article-title":"Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing","volume":"1","author":"Granada","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.jcin.2018.08.034_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addr.2017.05.015","article-title":"The Lutonix\u00ae drug-coated balloon: a novel drug delivery technology for the treatment of vascular disease","volume":"112","author":"Schorn","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jcin.2018.08.034_bib12","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jvir.2016.06.036","article-title":"Comparison of particulate embolization after femoral artery treatment with IN.PACT Admiral versus Lutonix 035 paclitaxel-coated balloons in healthy swine","volume":"27","author":"Kolodgie","year":"2016","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jcin.2018.08.034_bib13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jcin.2015.03.020","article-title":"Impact of paclitaxel dose on tissue pharmacokinetics and vascular healing: a comparative drug-coated balloon study in the familial hypercholesterolemic swine model of superficial femoral in-stent restenosis","volume":"8","author":"Gongora","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2018.08.034_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2018.08.034_bib15","first-page":"614","article-title":"Variability in freedom from loss of primary patency results in trials assessing stent implantation in the superficial femoral artery","volume":"26","author":"Vardi","year":"2014","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jcin.2018.08.034_bib16","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2018.08.034_bib17","unstructured":"Lutonix 035 Drug Coated Balloon PTA Catheter Instructions for Use. Available at: http:\/\/www.bardpv.com\/eifu\/uploads\/DW5190-01r7-Lutonix-DCB-IFU-with-GeoAlign.pdf. Accessed November 18, 2018."},{"key":"10.1016\/j.jcin.2018.08.034_bib18","unstructured":"IN.PACT Admiral Instructions for Use. Available at: http:\/\/manuals.medtronic.com\/content\/dam\/emanuals\/cardio\/M052624T001_Rev1H_view_color.pdf. Accessed November 18, 2018."}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879818320247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879818320247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:08:09Z","timestamp":1761847689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879818320247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":18,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1936879818320247"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2018.08.034","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2018.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}